Catch up on the most important updates from this week.
The FDA mulls boosters, states dispute vaccine mandates, and the US reaches yet another grim milestone. Here’s what you should know:
Want to receive this weekly roundup and other coronavirus news? Sign up here!
An FDA panel takes a close look at boosters amid controversy
Today the US Food and Drug Administration’s independent advisory committee is meeting to discuss whether booster doses of the Pfizer-BioNTech vaccine are safe and effective enough to warrant widespread use. The FDA will then make a formal decision, after which the Centers for Disease Control’s independent advisory panel will weigh
→ Continue reading at Wired - Science